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UltrastructureThe neuronal ceroid lipofuscinoses (NCL) currently encompass fourteen genetically different forms, CLN1 to
CLN14, but are all morphologically marked by loss of nerve cells, particularly in the cerebral and cerebellar
cortices, and the cerebral and extracerebral formation of lipopigments. These lipopigments show distinct
ultrastructural patterns, i.e., granular, curvilinear/rectilinear and ﬁngerprint proﬁles. They contain− although
to a different degree among the different CLN forms − subunit C of ATP synthase, saposins A and D, and
beta-amyloid proteins. Extracerebral pathology, apart from lipopigment formation, which provides diagnostic
information, is scant or non-existent. The retina undergoes atrophy in all childhood forms. While many new
data and ﬁndings have been obtained by immunohistochemistry in mouse and other animal models, similar
ﬁndings in human NCL are largely missing, thus recommending respective studies of archived brain tissues.
The newly described NCL forms, i.e., CLN 10 to CLN 14, also require further studies to provide complete
neuropathology. This article is part of a Special Issue entitled: “Current Research on the Neuronal Ceroid
Lipofuscinoses (Batten Disease)”.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
The neuronal ceroid lipofuscinoses (NCL) are diagnosed by muta-
tions, but deﬁned by morphological features− though diagnosed by
morphologywhen genetics are not available. Themorphological criteria
entail loss of neurons, especially in the cerebral and cerebellar cortices
and accumulation of lipopigments within cells. The former may, at
least partially, give rise to clinical symptoms and the latter to diagnosis.
The relationship between these two features, i.e., loss of neurons and
accretion of lipopigments (Figs. 1 and 2), is still insufﬁciently known.
Distribution and severity of cellular loss will best be appreciated by
autopsy which, however, will hardly inform about the dynamics of the
disease. As lipopigments accrue in almost every cell type and organ,
i.e., the central and peripheral nervous systems and extracerebral
tissues, the biopsy of easily accessible organs, e.g., blood lymphocytes,
skin, conjunctiva, and rectum, have readily been employed in the
diagnostic armamentarium. The main diagnostic tool for biopsies is
the electron microscope. Complete description of an NCL and its fullesearch on the Neuronal Ceroid
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l).nosological ascertainment may be based on both biopsy and autopsy
in an individual patient and individual form of NCL, of which so far 14
genetically identiﬁed forms exist, CLN1 to CLN14. As the morphologies
of autopsy and biopsy are overlapping, the complete pathology is best
illustrated by discussing the various levels of visual recognition, from
the naked eye to the light and electron microscopes.
2. Gross pathology
Macroscopic pathology is conﬁned to the central nervous system,
largely to the cerebrum and the cerebellum, whereas brainstem and
spinal cord appear rather unremarkable.
Long-term loss of nerve cells and their processes results in atrophy
(Fig. 1A), especially of the cerebral cortex and the cerebellum, together
with widening of the ventricles and the subarachnoid space. Looking at
the mantle of the brain, the gyri are reduced in thickness, the sulci are
gaping and the leptomeninges appear thickened, more severely in the
occipital lobes than the frontal ones. The smooth glistening surface of
the sectioned cerebral and cerebellar cortices may be replaced by a
gritty, occasionally spongy appearance, due to excessive loss of
nerve cells. The earlier neuronal death sets in, the more severe is at-
rophy, being farthest advanced in the infantile type and least in the
adult type. Reduced brain weights in the individual CLN forms are
given in Table 1.
However, a protracted course, for instance in CLN3, may further
advance the atrophy. In addition, by longstanding good care, with the
vital organs longer intact and the body in less severe decay, the brain
continues to shrink to further atrophy. Massive loss of neurons in the
Fig. 1. A: Atrophic cerebral cortex in infantile NCL.
B: Atrophic retina with only remnants of photoreceptor inner segments and
severe loss of neurons, CLN2, hematoxylin–eosin (originalmagniﬁcation: 16×).
C: Normal retina, hematoxylin-eosin (original magniﬁcation: 20×).
D: Numerous nerve cells, replete with SCMAS-containing lipopigements, CLN5
(original magniﬁcation: 16×).
E: Autoﬂuorescence of lipopigments in the cerebral cortex, infantile NCL (original
magniﬁcation: 40×).
F: Lipopigments in muscle ﬁbers display enhanced histochemical activity of acid
phosphatase (original magniﬁcation: 20×).
Table 1
Brain weight (grams) in CLN forms [34].
NCL type Brain weight (g)
CLN1 240–450
CLN2 500–700
CLN3 800–1000
CLN4 900–1245
CLN5 450–880
CLN6 455–880
CLN7 590–880
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spherical white matter, corpus callosum and long tracts, especially the
pyramidal tracts which can be observed at the medullary and spinal
cord levels. In CLN3, the substantia nigra may appear pale, perhaps
owing to impaired formation or loss of neuromelanin in respective neu-
ronal cell bodies. Juvenile and adult NCL brains may display a light
brownish or deep yellowhue of greymatter because of excessive forma-
tion of lipopigments in nerve cells before their depletion.Fig. 2. A: Compact GROD in a lymphocyte, infantile NCL (original magniﬁcation:
11000×).
B: Curvilinear proﬁles, classic late infantile NCL (original magniﬁcation:
21600×).
C: Fingerprint proﬁles in a lysosomal vacuole of a lymphocyte, juvenile NCL (orig-
inal magniﬁcation 21600×); Inset: Fingerprint proﬁles at high magniﬁcation.
D: GROD in vitamin E deﬁciency (original magniﬁcation, 21600×).3. Light microscopy
Histological abnormalities are variegated, sometimes contradicting
and often incomplete. Three different aspects prevail in the tissues, of
which the relationship to each other is not always clear: Firstly, the
loss of nerve cells, largely identiﬁed by loss of nerve cell bodies rather
than processes, is concomitant with subsequent reaction of microglia
and astrocytes as well as, secondly, loss of myelin due to axonal degen-
eration and, thirdly, accumulation of lipopigments. Only the latter
phenomenon is assessable in extracerebral organs while any additional
convincing histopathology in visceral and other organs, such as skin
or skeletal muscle, is largely absent. While with increasing age and
survival, especially of patients with juvenile NCL, cardiac symptoms,
frequently conduction defects, have become apparent, the few
cardiopathological reports emphasize the often heavy formation of
NCL lipopigments, with vacuolation and lipopigment formation of
ﬁngerprint and curvilinear proﬁles therein [1], particularly in the
conduction system [2,3] and degenerative myocardial pathology, fatty
substitution and ﬁbrosis [3,4].
In view of the wealth of modern techniques applicable to the tissues
in NCL, the knowledge of lesions within the central nervous system in
NCL is still incomplete. As gross pathology and histopathology of the cen-
tral nervous system are largely based on autopsies− brain biopsieswere
usually only studied for the diagnostic accumulation of lipopigments
and their ultrastructure, rather than structural pathology by light
microscopy − major and more complete autopsy reports date back
from the premolecular era and even from times when NCL was part of
the nosological group of “amaurotic familial idiocy,” and such often com-
prehensive, long, old-time reports are still perfectly valid when retroac-
tively associated with molecular data as provided for the original
neuropathological report on classical CLN2, the late infantile form of
Jansky–Bielschowsky [5–7]. Since that past history, NCL has been distin-
guished from other lysosomal diseases affecting the central nervous
system by showing autoﬂuorescence of enlarged nerve cells and has
also been subclassiﬁed in various forms, earlier called infantile, late in-
fantile, juvenile, and adult forms, but now enhanced by recent additional
molecular results from CLN1 to CLN14. On the other hand, availability of
autopsy tissues and the opportunity to study postmortem CNS by histo-
pathology have been diminished and severely hampered by the dwin-
dling numbers of autopsies. Hence, assessment of precise and complete
pathological changes across the entire neuraxis is still patchy.
At autopsy, the cortices of the cerebrum and the cerebellum may
variably be depleted of neurons. This emphasizes the fact that autopsy
studies usually pertain to the end stage of the disease which is most
advanced in the early-childhood forms, although in earlier times NCL
patients often died of infectious diseases, e.g., tuberculosis in particular,
thereby preventing progression of the NCL to reach its end stage. Loss of
neurons is evaluated by recording density and layering of neuronal
perikarya. Only a rare neuronal perikaryon may be present in the
depleted cortex in CLN1 or infantile NCL. Loss of cortical layers and
cytoarchitecture and its most severe form of tissue rarefaction, spongi-
ness of cortical areas, may be encountered [7]. Preferential loss of
neurons may only be recognized in NCL forms that, even at autopsy,
do not show near-complete neuronal depletion, e.g., in juvenile and
adult forms. Also, neuronal depletion and subsequent cortical atrophy
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occipital ones. According to earlier studies of rather thick tissue sections,
small neurons of layer II are preferentially affected [8,9]. Neurons of
layer V are also severely and early marked by loss.
Neuronal depletion in subcortical areas, i.e., the basal ganglia, the
brainstem, cerebellar nuclei and spinal cord, has fragmentarily been
reported, for instance in relation to the individual genetic forms of
CLN1 to CLN14. Neuronal loss in subcortical grey matter is variable in
degree, also dependent on the age of the diseased patient. The thalamus
and dentate nucleus may show depletion of neurons. True quantitative
studies, as well as those distinguishing different nerve cell classes
within a grey-matter complex, have not yet been procured. A prefer-
ential excessive formation of lipopigments has been observed in
small spiny neurons of the striatum while the aspiny neurons are less
affected [10].
Histological abnormalities, however, probably start earlier, outside
the neuronal perikarya because Golgi studies reveal dearth of dendritic
spines in apical dendrites, although lipopigments are not deposited here
[7]. This early degeneration may elicit a microglial response and impart
criteria of neuroinﬂammation. The activated microglia may have a
proinﬂammatory inﬂuence on the tissue and may further damage the
neuronal population. Together with microglial activation, macrophages
phagocytose cellular debris and lipopigments. Loss of neurons and their
axons causes breakdown of myelin and, thus, demyelination, although
largely of secondary nature. Finally, ﬁrst cellular astrocytosis and later
ﬁbrillar astrocytosis ensue and, hence, transform areas of preceding
primary nerve cell loss into scarred regions.
While immunohistochemistry focuses on the presence and type of
lipopigments− to be discussed later in this article− almost nothing
is known about immunohistochemical demonstration of CLN-speciﬁc
proteins and their mutant forms. Of the four enzyme proteins, i.e.,
PPT1 (CLN1), TPP1 (CLN2), cathepsin-D (CLN10), and cathepsin-F
(CLN13), apparently an antibody against TPP1 may demonstrate the
absence of the TPP1 protein in brain tissue. Cathepsin-D, deﬁcient in
CLN10, was immunohistochemically found absent in brain tissue in
congenital NCL [11]. Although antibodies against murine cln proteins
have been generated and employed, no such cln or CLN antibodies
have been applied to human tissue. Occasionally, immunohistochemi-
cal evidence of apoptosis has been provided [12]. A clear reaction,
both of micoglia and astrocytes, however, has immunohistochemically
been corroborated (own unpublished observation), demonstrating
early microglial reaction in grey-matter areas with little neuronal loss
indicating additional and, most likely, preceding damage to neuronal
processes. All in all, in viewof the diagnostic signiﬁcance of immunohis-
tochemistry, very little new information has been procured by NCL
brains, apart from the lipopigment composition.
Lipopigment formation, the hallmark of NCL among lysosomal
diseases, can be recognized by the presence of yellowish granules in
hematoxylin-eosin-stained sections of cerebral neurons, further corrob-
orated by PAS and lipid stains, such as Sudan black, autoﬂuorescence
(Fig. 1E) and, using frozen unﬁxed tissue, enhanced enzymehistochem-
ical activity of lysosomal acid phosphatase (Fig. 1F). Components of
the lipopigments can immunohistochemically be ascertained with anti-
bodies against the subunit C of mitochondrial ATP synthase (SCMAS,
Fig. 1D) and/or sphingolipid activator proteins (SAP) A and D. Although
SCMAS prevails in certain CLN forms, i.e., CLN2, CLN3, and CLN5 to CLN8,
SAP-A and -D predominate in others, i.e., CLN1 and CLN10. The presence
of both proteins, although not in equal amounts, may be encountered in
careful studies [13]. In several instances, the beta-A4 amyloid and the
amyloid precursor protein have been identiﬁed in lipopigments
[14,15]. Both, autoﬂuorescence and immunohistochemistry of SCMAS
and SAP not only outline the enlarged perikarya but also emphasize
lipopigment location in proximal axonal segments or axon spindles,
here – and in other respective neuronal lysosomal diseases – called
meganeuriteswhilst dendrites, except those of Purkinje cells, are devoid
of lipopigment storage.However, lipopigment deposition is not conﬁned to neurons butmay
also be encountered inmacrophages and astrocytes aswell asmural cells
of vessels. Furthermore, owing to the widespread extracerebral forma-
tion of NCL-speciﬁc lipopigments, these may also be demonstrated in
extracerebral ganglion cells of spinal and autonomic ganglia, including
those of the rectum– a target of biopsies in former times – and in visceral
organs at autopsy, and by biopsy, in more easily accessible organs,
such as skin, blood lymphocytes, skeletal muscle, conjunctiva, and rec-
tum because lipopigment deposits may be minuscule and, thus, not all
light microscopic techniques may be successful in demonstrating the
lipopigments. Hence electron microscopy is essential for diagnosis by
biopsy.
4. Retinal pathology
The retina is involved in the pathological process of NCL in all child-
hood forms (Fig. 1B, C), although in the different CLN forms visual prob-
lems and ﬁnal blindness not always appear in the forefront among
clinical symptoms. Postmortem studies on retina in NCL are scant, and
their pathology may or may not represent end-stage pathology. Thus,
the dynamics of retinal degeneration in NCL may only be recognized
by comparing postmortem retinal specimens of different CLN types. In
the end stage, the once ten-layered retina may appear transformed
into a broad glial scar devoid of any neuronal elements, but containing
pigment-carrying macrophages and pigment epithelium. Apparently,
retinal degeneration starts at the outer segments of the photoreceptors,
proceeding inward during the course of the disease. Loss of photorecep-
tors is more prominent in central regions. Sometime during the degen-
erative process, when the outer limiting membrane may have become
discontinued, proliferating retinal epithelial cells may migrate into
the atrophic retina and may scatter around intraretinal vessels, the
fundoscopic equivalent of the so-called “bone spicules.” NCL-speciﬁc
lipopigments may be seen in residual glial cells and macrophages, as
well as in immigrant retinal pigment epithelial cells, then mixed with
melanin granules. Loss of ganglion cells results in disappearance of
axons and, subsequently, theirmyelin sheaths, i.e., optic atrophy associat-
ed with gliosis. Retinal atrophy is most pronounced in CLN1 and CLN3,
less so in CLN2 (Fig. 1C). In CLN5, less severe pathology has brieﬂy been
described [16]. Here, the inner ganglion cell layer appeared most pro-
foundly affectedwith even photoreceptors preservedwhile lipopigments
accrued in the remaining ganglion cells and pigment epithelial cells,
together with melanin granules in the latter, but less in bipolar and pho-
toreceptor neurons. Gliosis was emphasized by immunohistochemical
evidence of glial ﬁbrillary acidic protein (GFAP).
Reports on autopsied retinas in adult NCL are even rarer. As visual
failure or blindness are frequently, but not always, absent in adult NCL
[17] and fundoscopic and electroretinographic ﬁndings also often are
unremarkable, absence of pathology from the retina may be inferred.
A postmortem study [18] on a 33-year-oldwomanwho had late adoles-
cence onset of molecularly proven CLN5 [19] revealed preservation of
all retinal layers including those of the photoreceptors, but lipopigment
formation was encountered in each neuronal cell type suggesting that
retinal degeneration and lipopigment formation may not be closely
associated.
5. Electron microscopy
NCL-speciﬁc lipopigments are divided into GROD (granular
osmiophilic deposits) and non-GROD ultrastructural patterns, the
former correlating well with accumulation of the SAP proteins, the
latter with the accumulation of the SCMAS, conﬁrmed by immuno-
electron microscopy [20]. GROD (Fig. 2A) is seen in CLN1, CLN4,
CLN10 and sometimes with non-GROD features in adult CLN6, CLN8
and CLN14 [21]. Non-GROD patterns are those of curvilinear proﬁles
(Fig. 2B), of which rectilinear proﬁles are probably a subtype, and
ﬁngerprint proﬁles (Fig. 2C), both of them appearing either separate
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These intralysosomal curvilinear or ﬁngerprint proﬁles form, electron
microscopically, conspicuous curvilinear bodies or ﬁngerprint bodies,
or mixed bodies. A topographical survey in different cerebral grey
matter areas of these various ultrastructural patterns have been given
for classic late infantile type Jansky–Bielschowsky and classic juvenile
type Spielmeyer–Sjögren [22].
In skeletal muscle, however, muscle ﬁbers only carry curvilinear/
rectilinear inclusions, no ﬁngerprint proﬁles [23], the latter may be
encountered in mural cells of skeletal muscle vessels. In CLN3, multiple
vacuolesmay be seen in blood lymphocytes [23], some ofwhich contain
ﬁngerprint proﬁles. Vacuolesmay also be encountered in secretory cells
of eccrine sweat glands in CLN3. Occasionally, peculiar “myoclonus bod-
ies” or spheroids are encountered in subcortical grey matter which;
however, lack NCL-speciﬁc ultrastructural patterns, have apparently
lost immunohistochemical reactivity to SCMAS antibodies, and can be
observed in CLN1, CLN3, CLN6, and especially in CLN2 [24].
In complex-structured extracerebral tissues, formation of NCL-
speciﬁc lipopigments may not be ubiquitous. For instance, in skin only
secretory not ductal cells of eccrine sweat glands carry NCL-speciﬁc
lipopigments, while apocrine sweat glands lack NCL-speciﬁc lipopigment
deposits. A comprehensive survey of NCL lipopigment ultrastructure out-
side of the brain has recently been provided [23,25] (Table 2). A picture of
other visceral organs, such as pancreas, adrenals, and kidney is not yet
completely known. Among circulating blood cells, only lymphocytes
and monocytes show NCL-speciﬁc lipopigment formation, but not
granulocytes or thrombocytes. Morphological prenatal investigation
aims at amniotic ﬂuid cells, fetal tissues, such as skin or blood lympho-
cytes, and often chorionic villi. In the latter, only endothelial cells may
show CLN-speciﬁc lipopigments while cytotrophoblasts, syntrophoblasts
andﬁbroblasts are spared [25,26]. The lipopigments in villous endothelial
cells may contain GROD in CLN1, curvilinear proﬁles in CLN2, 5, and 6,
and lamellar ﬁngerprint-like ultrastructure in CLN3 and variants [26].
Time may be an important factor in prenatal morphological investiga-
tion as at 11weeks no lipopigmentswere detected in villous endothelial
cells in molecularly proven CLN5, but at 14 weeks (end of pregnancy),
they were of curvilinear and lamellar ultrastructure [27]. Likewise,
lipopigments were not detected in fetal tissues at 14weeks of gestation
[27].
Lipopigments resembling those seen in NCL have also been
observed in other lysosomal diseases, both at the immunohistochemical
level – by demonstrating accumulation of SCMAS, a component of the
lipopigments in NCL [13] – as well as at the ultrastructural level
in other lysosomal diseases, such as GM1-gangliosidosis [28] orTable 2
MORPHOLOGICAL Characteristics of Human Neuronal Ceroid-Lipofuscinoses (NCLs)
(based on references [23] and [25]).
Disease Ultrastructure Stored protein
CLN1 GRODs SAPs
CLN2 CL SCMAS
CLN3 FP (CL, RL) SCMAS
CLN4 GRODs SAPs
CLN5 RL, CL, FP SCMAS
CLN6 RL,CL, FP SCMAS
CLN7 RL, FP SCMAS
CLN8 CL-like, FP, granular SCMAS
CLN9 GRODs, CL, FP SCMAS
CLN10 GRODs SAPs
CLN11 FP Not known
CLN12 FP Not known
CLN13 FP Not known
CLN14 RL, FP SCMAS
Abbreviations:
CL = curvilinear proﬁles; FP = ﬁngerprint proﬁles; RL = rectilinear proﬁles;
GRODs = granular osmiophilic deposits; SAPs = sphingolipid activator proteins;
SCMAS = subunit C of mitochondrial adenosine triphosphate synthase.mucopolysaccharidoses, especially type III A [29,30]. The ultrastructure
of these “associated” lipopigments appeared atypical or NCL non-
classical [28–30]. NCL-typical ultrastructural pattern, e.g., ﬁngerprint pro-
ﬁles, have also been seen in blood lymphocytes inmucopolysaccharidoses
[31].
Another ultrastructural differential diagnosis is the occurrence of
intralysosomal curvilinear proﬁles in chloroquine intoxication affecting
the skeletalmuscle, the retina, and other tissues. In vitamin E deﬁciency,
autoﬂuorescent, unltrastructurally ﬁnely granular lipopigments accrue
in neurons (Fig. 2D) and extracerebral tissues [32,33].
6. Conclusion
Autopsy studies have been performed on each of the childhood
forms of NCL, some of them rather recently, and are available in a
semi-detailed fashion [34] as well as molecularly undeﬁned adult NCL
[34], CLN4 [35–37], and CLN13 [38]. They emphasize the almost com-
plete to rather mild loss of neurons in cerebral and cerebellar cortices,
according to age of onset and CLN type. Subcortical pathology has
been described in varying detail while electron microscopy of the
NCL-speciﬁc lipopigments is well known in cerebral and extracerebral
tissues. Postmortem studies on cerebral and non-cerebral tissues of pa-
tients affected by CLN11 to CLN14, however, are incomplete (Table 3),
awaiting future conﬁrmatory and expanding investigations. Proceeding
microglial activation has introduced the concept of neuroinﬂammation,
particularly in murine and other animal models. Modern immunohisto-
chemical techniques have, however, been only scantily applied to
human brain tissues of which biopsied and autopsied samples are cer-
tainly available from numerous archives. Hence, retroactive studies on
such archival tissues are highly needed to compare their results with
those of spontaneous animal and genetically engineered mousemodels
to assess their signiﬁcance in human NCL brain and extracerebral
pathology. Such archival morphological investigations can and ought
to be supplemented and molecularly conﬁrmed by, for instance, Sanger
sequencing or other molecular techniques of isolated DNA from archival
tissue blocks. Future studies ﬁlling gaps in neuropathological knowledge
of recently described human NCL forms are also essential to evaluate to
which extent newly described CLN forms ﬁt within the nosological
framework of NCL.
Transparency Document
The http://dx.doi.org/10.1016/j.bbadis.2015.05.007Transparency
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version.Table 3
Ultrastructure and location of extracerebral lipopigments in recently identiﬁed forms of
Neuronal Ceroid Lipofuscinoses, reported so far.
NCL type
gene
Location EM
pattern
Reference
CLN4
DNAJC5
Rectal neurons
Lymphocytes
Eccrine sweat glands
GROD
GROD/CP
GROD
[39]
[40]
[36,37]
CLN10
CTSD
Skeletal muscle
Schwann cells
GROD
GROD
[41]
[42]
CLN11
GRN
Lymphocytes
Secretory eccrine sweat gland cells
FP
FP
[43]
[38]
CLN12
ATP13A2
Skeletal muscle: satellite cells, not myoﬁbers
Fibroblasts, peripheral nerve, endothelial cells,
pericytes perineurial cells, Schwann cells
lamellar [44,45]
CLN13
CTSF
Dermal ﬁbroblasts GROD, FP [46,47]
CLN14
KCTD7
Skin, ﬁbroblasts,
Secretory eccrine sweat gland cells
GROD, FP [48]
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